Patient-Reported Outcomes in Children with Moderately to Severely Active Polyarticular or Polyarticular-Course Juvenile Idiopathic Arthritis Who Are Prescribed and Treated with Adalimumab.

被引：0

作者：

Horneff, Gerd ^{[1
]}

Wallace, Carol A. ^{[2
,3
]}

Quartier, Pierre ^{[4
]}

Kingsbury, Daniel J. ^{[5
]}

Minden, Kirsten ^{[6
]}

Bereswill, Mareike ^{[7
]}

Garg, Vishvas ^{[8
]}

Kupper, Hartmut ^{[7
]}

Kalabic, Jasmina ^{[7
]}

机构：

[1] Asklepios Klin Sankt Augustin, St Augustin, Germany

[2] Univ Washington, Sch Med, Seattle, WA USA

[3] Seattle Childrens Hosp, Seattle, WA USA

[4] Univ Paris 05, Hop Necker Enfants Malad, AP HP, IMAGINE Inst, Paris, France

[5] Randall Childrens Hosp Legacy Emanuel, Portland, OR USA

[6] Kinderklin Charite, Otto Heubner Ctr, Berlin, Germany

[7] AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany

[8] AbbVie Inc, N Chicago, IL USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

289

引用

页码：S122 / S123

页数：2

共 40 条

[21] Improvement in Patient-Reported Outcomes in Patients Aged 2-5 Years with Polyarticular-Course JIA Treated with Subcutaneous Abatacept: 2-Year Results from a Phase III International Study
Brunner, Hermine
Tzaribachev, Nikolay
Louw, Ingrid
Anton, Jordi
Viola, Diego
Lauwerys, Bernard
Cuttica, Ruben J.
Quartier, Pierre
Gervais, Elisabeth
Belot, Alexandre
Minden, Kirsten
Lutz, Thomas
Cimaz, Rolando
Ally, Mahmood M. T. M.
van Zyl, Riana
Penades, Inmaculada Calvo
Zhuo, Joe
Wong, Robert
Nys, Marleen
Elbez, Yedid
Martini, Alberto
Lovell, Daniel J.
Ruperto, Nicolino
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[22] ABSENCE OF ASSOCIATION BETWEEN DRUG EXPOSURE AND INFECTION IN PATIENTS WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC OR NON-BIOLOGIC DMARDS TREATED WITH SC AND IV ABATACEPT
Ruperto, N.
Brunner, H.
Tzaribachev, N.
Louw, I.
Calvo, I.
Horneff, G.
Henrickson, M.
Rama, M. E.
Fischbach, M.
Miraval, T.
Ally, M. M.
Li, X.
Wong, R.
Nys, M.
Murthy, B.
Lin, K.
Passarell, J. A.
Martini, A.
Lovell, D. J.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 477 - 477
[23] Patient-Reported Outcome Response and Safety Profile in Patients With Moderately to Severely Active Rheumatoid Arthritis Treated With Baricitinib 2-mg
Sholter, Dalton
Wu, Jianmin
Jia, Bochao
Zhang, Hong
Griffing, Kirstin
Quebe, Amanda
Birt, Julie
Reis, Paulo
Liu, Huaxiang
Bingham, Clifton
[J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1109 - 1110
[24] Patient-Reported Outcomes of Upadacitinib versus Adalimumab Use in Patients with Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate: 26-Week Analysis of a Phase 3 Study
Fleischmann, Roy
Bergman, Martin
Tundia, Namita
Song, In-Ho
Suboticki, Jessica
Song, Yan
Strand, Vibeke
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[25] Associations Between the American College of Rheumatology Pediatric Response Measures and the Continuous Measures of Disease Activity Used in Adult Rheumatoid Arthritis A Secondary Analysis of Clinical Trial Data From Children With Polyarticular-Course Juvenile Idiopathic Arthritis
Ringold, Sarah
Chon, Yun
Singer, Nora G.
[J]. ARTHRITIS AND RHEUMATISM, 2009, 60 (12): : 3776 - 3783
[26] Cumulative Long-Term Safety, Efficacy and Patient-Reported Outcomes in Children With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept: Up to 7 Years of Treatment
Lovell, Daniel J.
Ruperto, Nicolino
Mouy, Richard
Paz, Eliana
Rubio-Perez, Nadina
Silva, Clovis A.
Abud-Mendoza, Carlos
Burgos-Vargas, Ruben
Gerloni, Valeria
Melo-Gomes, Jose A.
Magalhaes, Claudia Saad
Chavez-Corrales, Jose
Huemer, Christian
Kivitz, Alan J.
Blanco, Francisco J.
Foeldvari, Ivan
Hofer, Michael
Huppertz, Hans-Iko
Deslandre, Chantal
Minden, Kirsten
Block, Alan J.
Giannini, Edward H.
Martini, Alberto
[J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S218 - S219
[27] Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial
Violetta Opoka-Winiarska
Zbigniew Żuber
Ekaterina Alexeeva
Vyacheslav Chasnyk
Irina Nikishina
Grażyna Dębowska
Elżbieta Smolewska
[J]. Clinical Rheumatology, 2018, 37 : 1807 - 1816
[28] Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial
Opoka-Winiarska, Violetta
Zuber, Zbigniew
Alexeeva, Ekaterina
Chasnyk, Vyacheslav
Nikishina, Irina
Debowska, Grazyna
Smolewska, Elzbieta
[J]. CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1807 - 1816
[29] UPADACITINIB MONOTHERAPY IMPROVES PATIENT-REPORTED OUTCOMES IN METHOTREXATE-NAIVE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS: RESULTS FROM SELECT-EARLY
Strand, Vibeke
Tundia, Namita
Radominski, Sebastiao
Friedman, Alan
Dunlap, Kendall
Goldschmidt, Deborah
Bergman, Martin
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 372 - 373
[30] Marked Improvement In Patient Reported Outcomes Of Children With Active Systemic Juvenile Idiopathic Arthritis With Canakinumab Treatment - Results Of The Phase III Program
Schneider, Rayfel
Brunner, Hermine I.
Ruperto, Nicolino
Wulffraat, Nico
Quartier, Pierre
Brik, Riva
McCann, Liza
Foster, Helen E.
Frosch, Michael
Gerloni, Valeria
Harel, Liora
Len, Claudio
Houghton, Kristin
Joos, Rik
Abrams, Ken
Lheritier, Karine
Kessabi, Sophia
Martini, Alberto
Lovell, Daniel J.
[J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S111 - S112

← 1 2 3 4 →